Disc Medicine IRON Cash Provided by (Used in) Financing Activity, Including Discontinued Operation
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation at other companies
Other financials
Where this comes from
Reported directly by Disc Medicine in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: Disc Medicine’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Disc Medicine's cash provided by (used in) financing activity, including discontinued operation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Disc Medicine's cash provided by (used in) financing activity, including discontinued operation?
- Disc Medicine (IRON) reported cash provided by (used in) financing activity, including discontinued operation of $1.7M in Q1 2026.
- How has Disc Medicine's cash provided by (used in) financing activity, including discontinued operation changed year-over-year?
- Disc Medicine's cash provided by (used in) financing activity, including discontinued operation decreased by 99.3% year-over-year, from $244.25M to $1.7M.
- What is the long-term trend for Disc Medicine's cash provided by (used in) financing activity, including discontinued operation?
- Over 3 years (2022 to 2025), Disc Medicine's cash provided by (used in) financing activity, including discontinued operation has grown at a 47.0% compound annual growth rate (CAGR), from $148.98M to $473.41M.
- What does cash provided by (used in) financing activity, including discontinued operation mean?
- This metric measures the net cash flow between the company and its capital providers, including proceeds from debt or equity issuance and payments for dividends or share repurchases. It highlights how the company finances its operations and returns value to shareholders.